Argenica Therapeutics Management
Management criteria checks 0/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Key information
Liz Dallimore
Chief executive officer
AU$675.0k
Total compensation
CEO salary percentage | 37.0% |
CEO tenure | 2yrs |
CEO ownership | 0.05% |
Management average tenure | no data |
Board average tenure | 2yrs |
Recent management updates
Recent updates
Companies Like Argenica Therapeutics (ASX:AGN) Are In A Position To Invest In Growth
Jan 12Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business
Jul 20Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business
Apr 20We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate
Nov 30Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans
Aug 12Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation
Apr 29Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation
Dec 30We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate
Sep 16CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -AU$5m |
Sep 30 2023 | n/a | n/a | -AU$5m |
Jun 30 2023 | AU$675k | AU$250k | -AU$5m |
Mar 31 2023 | n/a | n/a | -AU$4m |
Dec 31 2022 | n/a | n/a | -AU$4m |
Sep 30 2022 | n/a | n/a | -AU$4m |
Jun 30 2022 | AU$337k | AU$228k | -AU$4m |
Mar 31 2022 | n/a | n/a | -AU$3m |
Dec 31 2021 | n/a | n/a | -AU$3m |
Sep 30 2021 | n/a | n/a | -AU$2m |
Jun 30 2021 | AU$145k | AU$31k | -AU$1m |
Vergütung im Vergleich zum Markt: LizDie Gesamtvergütung ($USD444.05K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Australian ($USD295.83K).
Entschädigung vs. Einkommen: LizDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.
CEO
Liz Dallimore
2yrs
Tenure
AU$674,955
Compensation
Dr. Liz Dallimore (B. Sc. (Hons), MBA, PhD, GAICD) serves as Chief Executive Officer of Argenica Therapeutics Limited ands serves as its Managing Director and Director since April 4, 2022. She is a researc...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Director | 2yrs | AU$674.96k | 0.050% A$ 33.4k | |
Non-Executive Chairman | less than a year | no data | no data | |
Member of Clinical Advisory Committee | no data | no data | no data | |
Independent Non-Executive Director | 3.3yrs | AU$36.90k | 0.49% A$ 325.4k | |
Independent Non-Executive Director | 3.3yrs | AU$36.90k | 0.13% A$ 83.4k | |
Non-Executive Director | no data | AU$83.31k | 4.45% A$ 3.0m | |
Member of Clinical Advisory Committee | no data | no data | no data | |
Member of Clinical Advisory Committee | no data | no data | no data | |
Chairman of Clinical Advisory Committee | no data | no data | no data | |
Member of Clinical Advisory Committee | 1.8yrs | no data | no data |
2.0yrs
Average Tenure
Erfahrener Vorstand: AGNDie Vorstandsmitglieder gelten nicht als erfahren ( 1.8 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.